MDS research criteria for prodromal Parkinson's disease
Daniela Berg(Christian-Albrechts-Universität zu Kiel), Günther Deuschl(Christian-Albrechts-Universität zu Kiel), Christopher G. Goetz(Rush University Medical Center), Charles H. Adler(WinnMed), Ronald B. Postuma(Montreal Neurological Institute and Hospital), Bastiaan R. Bloem(Radboud University Nijmegen), Glenda M. Halliday(UNSW Sydney), Piu Chan(Capital Medical University), Werner Poewe(University of Verona), Wolfgang H. Oertel(Philipps University of Marburg), José Á. Obeso(Biomedical Research Networking Center on Neurodegenerative Diseases), Thomas Gasser(Hertie Institute for Clinical Brain Research), Matthew Stern(Penn Center for AIDS Research), Inga Liepelt‐Scarfone(German Center for Neurodegenerative Diseases), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Kenneth Marek(University of Pennsylvania), Lawrence Joseph(McGill University Health Centre), Anthony E. Lang(Unknown), Bruno Dubois(Université de Lille), Irene Litvan(Johns Hopkins University)
Cited by 1,289
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k